UBS Group Begins Coverage on Avadel Pharmaceuticals (NASDAQ:AVDL)
Stock analysts at UBS Group initiated coverage on shares of Avadel Pharmaceuticals (NASDAQ:AVDL – Get Free Report) in a research report issued to clients and investors on Tuesday, Briefing.com reports. The brokerage set a “buy” rating and a $21.00 price …